Quidel’s Sofia® family of rapid testing is changing how laboratories view rapid testing. Sofia is a diagnostic testing platform, which takes rapid testing to a whole new level by integrating proven lateral-flow technology with advanced fluorescent chemistry. The Sofia platform combines this advanced assay technology with a small bench-top analyzer that can be deployed and used in both near-patient testing and laboratory settings. Sofia literally changes the way your customers view rapid testing.
Sofia test kits are simple-to-use, which makes Sofia adaptable to a variety of healthcare settings, from small physician offices to large hospital labs or emergency departments. As demonstrated by numerous studies and peer-reviewed publications, Sofia offers highly accurate, objective results, which can be delivered in two workflow modes to flex with seasonality. Sofia offers several unique laboratory management benefits compared to most other rapid lateral-flow tests, visually read or instrumented. Sofia stores and provides your customers the ability to access all user data, including testing, QC and calibration activity and offers barcode interfacing for patient and user identification. The comprehensive menu of CLIA-waived testing offered on Sofia includes: Influenza A+B FIA, RSV FIA and Group A Strep+ FIA. Sofia also offers Urine hCG FIA and Group A Strep in moderately complex kits.
Better access to better data
Sofia offers users the ability to connect to LIS or remotely manage their data through the use of the Quidel Virena® Wireless system. Virena is a unique wireless surveillance and data management program that works in harmony with – and adds value to – your customers’ Sofia system. Imagine your customers being able to monitor QC and operator performance across every site in their organization, easily accessing test usage data (by operator, facility and/or an organization) for inventory management and workload requirements, all from their office. Virena allows users to easily generate and visualize dynamic reports, which chart test results and automatically calculate percent positives (prevalence) for all Sofia assays. Virena allows authorized users access to these enterprise benefits in a highly secure environment from any web-connected device.
What’s new with Sofia?
Most recently, Quidel received simultaneous FDA clearance and CLIA waiver for the Sofia Strep A+ FIA, which was the first such achievement under the FDA’s new dual-submission program. Sofia Strep A+ FIA has been compared to culture with discordant specimens resolved by an FDAcleared molecular assay in the label, which demonstrates its high sensitivity, specificity and negative predictive values. This test provides your customers with highly accurate results in 5 minutes with the laboratory management functionality of Sofia. For more information on Quidel and the Sofia platform, contact Quidel Customer Service at 1.800.874.1517, or visit us at quidel.com.
Editor’s note: Sponsored by Quidel